Updates to Website

All walks of life. If you can rock with us, you are one of us.

For the time being register with Protonmail until I can check with G-Mail.

If you are a refugee from the Kiwifarms and looking for a place to hang your hat, you are welcome to join us

Topics of Interest

Covid Vaccine Megathread

Well, getting the vaccine is now a requirement for the building I'm working in.

I went today and got the first shot and my arms (including the one not shot) felt sore immediately after, but otherwise everything was fine on the ride back home. Then I got really drowsy and needed to sleep the rest of the day.

So far no adverse reactions just a fucked sleep schedule.

I'm mildly worried about the second one since at least one person I know was sick for a week after getting it. At least there is no out-of-pocket cost.
 
kiwifaggot said:
Well, getting the vaccine is now a requirement for the building I'm working in.

I went today and got the first shot and my arms (including the one not shot) felt sore immediately after, but otherwise everything was fine on the ride back home. Then I got really drowsy and needed to sleep the rest of the day.

So far no adverse reactions just a fucked sleep schedule.

I'm mildly worried about the second one since at least one person I know was sick for a week after getting it. At least there is no out-of-pocket cost.
Click to expand...
You gon get chipd next
 
kiwifaggot said:
Well, getting the vaccine is now a requirement for the building I'm working in.

I went today and got the first shot and my arms (including the one not shot) felt sore immediately after, but otherwise everything was fine on the ride back home. Then I got really drowsy and needed to sleep the rest of the day.

So far no adverse reactions just a fucked sleep schedule.

I'm mildly worried about the second one since at least one person I know was sick for a week after getting it. At least there is no out-of-pocket cost.
Click to expand...
Get herded nigger cattle.
 

There is a link between AstraZeneca's COVID-19 vaccine and very rare blood clots in the brain but the possible causes are still unknown, a senior official for the European Medicines Agency (EMA) said in an interview published on Tuesday.

However, the EMA later said in a statement that its review of the vaccine was ongoing and it expected to announce its findings on Wednesday or Thursday. An AstraZeneca spokesman declined to comment on the matter.


"In my opinion, we can now say it, it is clear that there is an association (of the brain blood clots) with the vaccine. However, we still do not know what causes this reaction," Marco Cavaleri, chair of the vaccine evaulation team at the EMA, told Italian daily Il Messagero.

Cavaleri provided no evidence to support his comment.

The EMA has repeatedly said the benefits of the AstraZeneca shot outweigh the risks as it investigates 44 reports of an extremely rare brain clotting ailment known as cerebral venous sinus thrombosis (CVST) out of 9.2 million people in the European Economic Area who have received the vaccine.


The World Health Organization has also backed the vaccine.

AstraZeneca has said previously its studies have found no higher risk of clots because of its vaccine.

Cavaleri said the EMA would say in its review that there is a link but was not likely to give an indication this week regarding the age of individuals to whom the AstraZeneca shot should be given.

Some countries, including France, Germany and the Netherlands, have suspending the use of the vaccine in younger people while the investigations continue.

REVIEW ONGOING
In response to Cavaleri's comments, the Amsterdam-based EMA said in a statement on Tuesday: "EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) has not yet reached a conclusion and the review (of any possible link) is currently ongoing."

The EMA said last week that its review had at present not identified any specific risk factors, such as age, gender or a previous medical history of clotting disorders, for these very rare events. A causal link with the vaccine is not proven, but is possible and further analysis is continuing, the agency said.

A high proportion among the reported cases affected young and middle-aged women but that did not lead EMA to conclude this cohort was particularly at risk from AstraZeneca's shot.
Scientists are exploring several possibilities that might explain the extremely rare brain blood clots that occurred in individuals in the days and weeks after receiving the AstraZeneca vaccine.

European investigators have put forward one theory that the vaccine triggers an unusual antibody in some rare cases; others are trying to understand whether the cases are linked with birth control pills.

But many scientists say there is no definitive evidence and it is not clear whether or why AstraZeneca's vaccine would cause an issue not shared by other vaccines that target a similar part of the coronavirus.

In a separate interview, Armando Genazzani, a member of the EMA's Committee for Medicinal Products for Human Use (CHMP), told La Stampa daily that it was "plausible" that the blood clots were correlated with the AstraZeneca vaccine.

The AstraZeneca vaccine is based on a modified chimpanzee adenovirus vector, ChAdOx1, developed at Oxford University, and is one of several adenovirus-vector COVID-19 vaccines. The current vaccine rollout represents the first use of viral vector vaccines on such a global scale.
Click to expand...

Don't get AstraZeneca.
 
Looks like Gavin is feeling confident:
www.cnn.com

California says it will fully reopen in June, citing falling Covid-19 case rates | CNN

California, the first state to implement a lockdown for the coronavirus pandemic, plans to fully reopen activities and businesses beginning June 15, state officials said Tuesday.
www.cnn.com www.cnn.com

California says it will fully reopen in June, citing falling Covid-19 case rates​


By Jason Hanna, Cheri Mossburg and Madeline Holcombe, CNN
Updated 5:33 PM ET, Tue April 6, 2021

California, the first state to implement a lockdown for the coronavirus pandemic, plans to fully reopen activities and businesses beginning June 15, state officials said Tuesday.

Falling infection rates, low hospitalizations and rising vaccinations are reasons this can be done, state Health and Human Services Secretary Mark Ghaly said.
California's mask mandate, however, would remain in place at least "in the short run," Gov. Gavin Newsom said.
The state's return to normal is subject to ongoing mask wearing and ongoing vigilance, Newsom said, along with a continued supply of vaccines.
"Looking 10 weeks out," Newsom said, "our expectation is ... everybody that would want the vaccine will have the opportunity to receive a vaccine."
California's announcement comes as some health experts have asked states to delay reopening so that more people can be vaccinated to fight off the spread of more-contagious variants, which they say is contributing to rising cases in parts of the US.
Dr. Seema Yasmin, an epidemiologist and CNN medical analyst, noted that California is waiting -- more than two months -- before fully reopening and that any sour circumstances before then still could change the state's plans.
"We have to really make sure that we don't drop our guard down," Yasmin told CNN on Tuesday.
As part of the June 15 reopening, Ghaly said, California will abandon its four-tier system that helps determine how open a county could be based on metrics like case rates and positivity rates.
Ghaly, too, said the date could be adjusted.
"We're looking at the supply and availability of vaccines. If the supply isn't there, we may make some tweaks to that June 15 date," he said, adding that "necessary precautions" would also be taken if Covid-19 hospitalizations rise.
Health officials will use science and data to guide the reopening, and variants will be closely monitored, Ghaly said.

Test positivity rate much lower in California​

Cases in California are down sharply from the winter, though the decline has leveled off in recent weeks.
The state averaged more than 2,700 new cases over the last week -- roughly the same average from two weeks ago, but way below a peak average of about 46,000 new daily cases back on December 21, Johns Hopkins University data show.
Newsom boasted Monday that California has the lowest Covid-19 positivity rate in the nation at 1.7%, far from its peak of 17.1% in early January.
The US test positivity rate averaged 5.71% over the seven days, as of Saturday, US Health and Human Services data show. The World Health Organization last year advised governments not to reopen until test positivity rates were 5% or lower for at least 14 days.
California has no plan to impose a vaccine passport plan system, but some sectors, such as large conventions with more than 5,000 people, will be required to demonstrate that all attendees are either vaccinated or tested, officials said. That restriction will remain in place until October 1.
Click to expand...
 
You must log in or register to reply here.
Back
Top